MaxCyte Balance Sheet Health
Financial Health criteria checks 6/6
MaxCyte has a total shareholder equity of $221.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $251.5M and $30.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$157.33m |
Equity | US$221.26m |
Total liabilities | US$30.24m |
Total assets | US$251.50m |
Recent financial health updates
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation
Mar 07Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation
Aug 12We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth
Apr 27Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth
Nov 20Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation
Mar 02We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth
Nov 17Recent updates
MaxCyte, Inc. (LON:MXCT) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 09Investors Appear Satisfied With MaxCyte, Inc.'s (LON:MXCT) Prospects As Shares Rocket 27%
May 30Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results
May 10Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term
Mar 14Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation
Mar 07Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%
Oct 07Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation
Aug 12MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%
May 15Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%
May 14We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth
Apr 27Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth
Nov 20Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation
Mar 02We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth
Nov 17We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn
Jul 25MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain
Feb 22Financial Position Analysis
Short Term Liabilities: MXCT's short term assets ($175.6M) exceed its short term liabilities ($12.3M).
Long Term Liabilities: MXCT's short term assets ($175.6M) exceed its long term liabilities ($18.0M).
Debt to Equity History and Analysis
Debt Level: MXCT is debt free.
Reducing Debt: MXCT had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MXCT has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: MXCT has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 22.5% each year